PlumX Metrics
Embed PlumX Metrics

Hematin therapy in porphyric attacks

Klinische Wochenschrift, ISSN: 0023-2173, Vol: 58, Issue: 16, Page: 829-832
1980
  • 25
    Citations
  • 0
    Usage
  • 10
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

We report our experience with hematin in the treatment of 57 patients in porphyric attacks. The ratio of acute intermittent porphyria: variegate porphyria: hereditary coproporphyria was 43:11:3. More than 90% of the patients showed not only a decline in their porphyrin precursors, but also a favorable clinical response. Hematin was well tolerated and should be considered the treatment of choice in porphyric relapse. © 1980 Springer-Verlag.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know